阅读说明：本技术 对携带her2外显子21插入的癌细胞具有抗肿瘤活性的化合物 (Compounds having antitumor activity against cancer cells carrying an insertion of exon 21 of HER2 ) 是由 J·罗比丘 J·V·海马赫 于 2020-03-27 设计创作，主要内容包括：本公开提供了通过施用第三代酪氨酸激酶抑制剂(例如,波齐替尼)治疗确定具有HER2外显子21突变的患者的癌症的方法。(The present disclosure provides methods of treating cancer in patients identified as having a HER2 exon 21 mutation by administering a third generation tyrosine kinase inhibitor (e.g., bosutinib).)